Press releases

Quantum Surgical receives €2 million from BpiFrance for the development of its next-gen robotized platform

Published on
February 4, 2020
Press Contact

Montpellier, France, Tuesday, January 21, 2020 – Quantum Surgical, an innovative company specializing in medical robotics, announces it has secured “Deeptech” development funding from Bpifrance for the development of its robotic platform designed to assist with minimally invasive surgical treatments in oncology.

This funding comes from Bpifrance’s “Deeptech” fund, which includes grants and repayable advances. Its objective is to support companies engaged in “Deeptech”-certified technological innovation projects involving industrial research and/or experimental development, with the aim of developing innovative products, processes, or services that offer tangible prospects for industrialization and commercialization.

“We are very pleased to receive this new support from Bpifrance, which is backing us in this exciting venture. This funding will allow us to accelerate the development of our innovative platform to benefit both patients and practitioners,” said Bertin Nahum, President and Founder of Quantum Surgical.

The future of minimally invasive cancer treatment is today.